SGBI Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (17 Jan 2024 @ 14:24):

Stats
Today's Volume	200 000
Average Volume	0.00
Market Cap	314 853
EPS	$-0.000390 ( 2023-03-30 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0.00100 (66.67%)

Insider Trading

Date	Person	Action	Amount	type
2022-06-30	Striepe Thomas	Sell	0	Common Stock
2022-06-30	Schmelz Hubertus	Sell	0	Common Stock
2021-10-13	Schmelz Hubertus	Buy	1 200 000	Common Stock
2021-06-30	Schmelz Hubertus	Sell	0	Common Stock
2021-06-30	Striepe Thomas	Sell	0	Common Stock

INSIDER POWER
0.00
Last 82 transactions
Buy: 3 836 313 \| Sell: 156 955

Volume Correlation

Long: -0.01 (neutral)

Short: 0.00 (neutral)

Signal:(41.164) Neutral

Sangui Biotech Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Sangui Biotech Correlation - Currency/Commodity

-0.02
( neutral )

0.13
( neutral )

0.00
( neutral )

0.23
( neutral )

Sangui Biotech Financials

Annual	2022
Revenue:	$69 190.00
Gross Profit:	$69 190.00 (100.00 %)
EPS:	$0.000100

Q3	2023
Revenue:	$18 697.00
Gross Profit:	$18 697.00 (100.00 %)
EPS:	$-0.000400

Q2	2023
Revenue:	$10 627.00
Gross Profit:	$10 627.00 (100.00 %)
EPS:	$-0.000800

Q1	2023
Revenue:	$41 029.00
Gross Profit:	$41 029.00 (100.00 %)
EPS:	$0.000300

Financial Reports:

No articles found.

Sangui Biotech

Sangui Biotech International, Inc., through its subsidiary, Sangui BioTech GmbH, develops hemoglobin-based artificial oxygen carriers for use as blood additives, blood volume substitutes, and variant products. The company's artificial oxygen carriers provide oxygen transport in humans in the event of acute and/or chronic lack of oxygen due to arterial occlusion, anemia, or blood loss, as well as chronic wounds. It also offers nano formulations for the regeneration of skin, including skin moisturization and enhanced skin elasticity; Chitoskin wound pads for supporting wound healing; and Hemospray wound spray, a medical product that is used for the healing of chronic wounds. The company sells its wound spray products under the Granulox brand name primarily in Europe and Mexico; and cosmetics products through internet shop. Sangui Biotech International, Inc. was incorporated in 1995 and is headquartered in Hamburg, Germany.